Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorRennes University Hospital
About this trial
The aim of the NODAL clinical trial is to demonstrate the feasibility of new, low-cost, non-invasive biomarkers of neurodegenerative pathologies as early Alzheimer and Parkinson, based on the estimation of the multimodal connectome.
Eligibility criteria
Qualifiers
French mother tongue
right-handed
with a level of education equal to or higher than the Certificat d'Études Primaires (Primary School Certificate)
Free of any medical or psychiatric condition likely to interfere with cognition (excluding diagnosis for patients)
Disqualifiers
All participants (healthy volunteers and patients)
Abdominal circumference + upper limbs sticking to the body > 200 cm;
Implantable pacemaker or defibrillator;
Neurosurgical clips;
Trial design
Treatments tested in this trial
- fMRI
- CONFMEM
Treatment groups
120 Participants
are divided into 5 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov